Clarus Announces Second Quarter 2004 Results STAMFORD, Conn., Aug.
5 /PRNewswire-FirstCall/ -- Clarus Corporation (NASDAQ:CLRS) today
announced financial results for the quarter ended June 30, 2004.
Clarus reported no revenues for the second quarter of 2004,
compared to $25,000 from the recognition of deferred software
service fees during the comparable period of 2003. Net loss for the
second quarter of 2004 was $963,000 or $0.06 per diluted share
compared to a net loss of $1.0 million or $0.07 per diluted share
during the comparable period of 2003. As of June 30, 2004, Clarus'
cash, cash equivalents and marketable securities were $85.0 million
(or $5.12 gross cash per share(1)) compared to $88.7 million as of
December 31, 2003. Clarus estimates that it has available net
operating loss, capital loss, research and experimentation credit
and alternative minimum tax credit carryforwards for U.S. federal
income tax purposes of approximately $113.8 million, $15.2 million,
$1.3 million and $53,000, respectively, which expire in varying
amounts beginning in the year 2009 to the extent not limited under
section 382 of the Internal Revenue Code. Clarus has also incurred
foreign losses in the amount of approximately $4.0 million that are
available to offset future taxable income in foreign jurisdictions.
As reported in its June 25, 2004 press release, the Company is
currently engaged in negotiation of a significant transaction to
redeploy its assets, however, there can be no assurance that this
transaction will be consummated. On June 22, 2004, the Company
received notice from the staff of The Nasdaq Stock Market that the
Company's common stock would be delisted from the Nasdaq National
Market effective as of the opening of business on July 1, 2004. The
Company has appealed such delisting to the Nasdaq Listing
Qualification Panel and such appeal will stay the delisting of the
Company's securities pending the Panel's decision. On July 1, 2004,
the Company entered into a memorandum of understanding to settle a
securities class action brought against the Company that was
originally filed in 2000. Pursuant to the memorandum, the Company
agreed in principle to settle the lawsuit in exchange for a payment
of $4.5 million, which is expected to be covered by insurance. The
final settlement of the consolidated class action is subject to
certain action including the execution of definitive documentation
and approval by the Court. Nigel Ekern, Clarus' Chief
Administrative Officer stated, "We continue to be actively engaged
in the negotiation of a significant transaction as part of our
strategy to redeploy our cash and utilize our NOL's, to the extent
available. Of course, no assurance can be given that this
transaction will be consummated. Also, we are pleased that the
securities class action lawsuit has been settled and that the
settlement payment is expected to be covered by our insurance
carriers." Clarus does not currently intend to hold conference
calls to discuss quarterly earnings releases unless we consummate
an acquisition in connection with our redeployment strategy. At
such time, we plan to resume holding quarterly conference calls to
review earnings and our operating performance. Clarus, formerly a
provider of e-commerce business solutions, is seeking to redeploy
its assets and use its substantial cash and cash equivalent assets
to enhance stockholder value. (1) Gross cash per share at June 30,
2004 equals cash, cash equivalents and marketable securities of
$85.0 million divided by 16.6 million common shares outstanding.
Clarus has provided this Non-GAAP measure because it believes that
it is useful to investors assessing the extent of the Clarus'
assets available for redeployment. Clarus is unaware of any
comparable GAAP measure. This press release contains
forward-looking statements within the meaning of the Securities Act
of 1933 and the Exchange Act of 1934. Information in this release
includes Clarus' beliefs, expectations, intentions and strategies
regarding Clarus, its future and its products and services.
Assumptions relating to the forward-looking statements involve
judgments with respect to, among other things, future economic,
competitive and market conditions and future business decisions,
all of which are difficult or impossible to predict accurately and
many of which are beyond our control. Actual results could differ
materially from those projected in the forward-looking statements
as a result of certain risks including our inability to execute
successfully our planned effort to redeploy our assets to enhance
stockholder value, the unavailability of our net operating loss
carry forward, and that the unaudited financial information
provided in this press release may be adjusted as a result of the
year end audit. Clarus cannot guarantee its future performance. All
forward-looking statements contained in this release are based on
information available to Clarus as of the date of this release and
Clarus assumes no obligation to update the forward-looking
statements contained herein. For further information regarding the
risks and uncertainties in connection with Clarus' business, please
refer to the "Management's Discussion and Analysis of Financial
Condition and Results of Operations" and "Factors That May Affect
Our Future Results" sections of Clarus' filings with the Securities
and Exchange Commission, including but not limited to, its most
recent annual report on Form 10-K and quarterly reports on Form
10-Q, copies of which may be obtained at the SEC's web site at
http://www.sec.gov/. CLARUS CORPORATION CONDENSED CONSOLIDATED
BALANCE SHEETS (UNAUDITED) (IN THOUSANDS, EXCEPT SHARE AND PER
SHARE AMOUNTS) JUNE 30, DECEMBER 31, 2004 2003 ASSETS CURRENT
ASSETS: Cash and cash equivalents $34,798 $15,045 Marketable
securities 50,150 73,685 Interest receivable 666 507 Prepaids and
other current assets 698 132 Total current assets 86,312 89,369
PROPERTY AND EQUIPMENT, NET 2,458 38 OTHER ASSETS: Deposits and
other long-term assets 1,536 38 TOTAL ASSETS $90,306 $89,445
LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts
payable and accrued liabilities $3,357 $1,520 Deferred revenue
1,106 1,106 Total current liabilities 4,463 2,626 LONG-TERM
LIABILITIES: Other long-term liabilities 41 -- Total liabilities
4,504 2,626 STOCKHOLDERS' EQUITY: Preferred stock, $.0001 par
value; 5,000,000 shares authorized; none issued -- -- Common stock,
$.0001 par value; 100,000,000 shares authorized; 16,663,240 and
16,649,048 shares issued and 16,588,240 and 16,574,048 outstanding
in 2004 and 2003, respectively 2 2 Additional paid-in capital
369,232 367,031 Accumulated deficit (278,201) (276,767) Treasury
stock, at cost (2) (2) Accumulated other comprehensive income (129)
(17) Deferred compensation (5,100) (3,428) Total stockholders'
equity 85,802 86,819 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
$90,306 $89,445 CLARUS CORPORATION CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS (UNAUDITED) (IN THOUSANDS, EXCEPT PER
SHARE AMOUNTS) THREE MONTHS SIX MONTHS ENDED JUNE 30, ENDED JUNE
30, 2004 2003 2004 2003 REVENUES: Services fees $-- $25 $-- $78
Total revenues -- 25 -- 78 COST OF REVENUES: Services fees -- -- --
-- Total cost of revenues -- -- -- -- OPERATING EXPENSES: General
and administrative 1,202 1,522 1,925 3,831 Depreciation and
amortization 14 -- 14 761 Total operating expenses 1,216 1,522
1,939 4,592 OPERATING LOSS (1,216) (1,497) (1,939) (4,514) OTHER
INCOME -- 75 17 380 INTEREST INCOME 253 390 487 748 INTEREST
EXPENSE -- 10 -- 66 NET LOSS $(963) $(1,042) $(1,435) $(3,452) Loss
per common share: Basic $(0.06) $(0.07) $(0.09) $(0.22) Diluted
$(0.06) $(0.07) $(0.09) $(0.22) Weighted average shares
outstanding: Basic 16,082 15,884 16,082 15,812 Diluted 16,082
15,884 16,082 15,812 CLARUS CORPORATION CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS (UNAUDITED) (IN THOUSANDS, EXCEPT SHARE
AMOUNTS) SIX MONTHS ENDED JUNE 30, 2004 2003 OPERATING ACTIVITIES:
Net loss $(1,434) $(3,452) Adjustments to reconcile net loss to net
cash used in operating activities: Depreciation and amortization on
property and equipment 14 761 Amortization of deferred employee
compensation 478 -- Noncash other -- (70) Amortization of premium
on purchase of marketable securities 707 -- Gain on sale of
marketable securities (17) -- Non-cash general and administrative
expense -- 86 Provision for doubtful accounts -- (67) Loss on
disposal of assets -- 37 Changes in operating assets and
liabilities: Accounts receivable -- 534 Prepaid and other current
assets (725) 252 Assets held for sale -- 48 Deposits and other
long-term assets -- 8 Accounts payable and accrued liabilities
(484) 12 Deferred revenue -- (79) Liabilities to be assumed --
(220) Other long-term liabilities 41 -- NET CASH USED IN OPERATING
ACTIVITIES (1,420) (2,150) INVESTING ACTIVITIES: Purchases of
marketable securities (47,587) (109,823) Proceeds from sale of
marketable securities 51,244 125,629 Proceeds from maturity of
marketable securities 19,076 -- Proceeds from sale of equipment --
11 Increase in transaction costs (97) 8 Purchases of property and
equipment (1,514) (4) NET CASH PROVIDED BY INVESTING ACTIVITIES
21,122 15,813 FINANCING ACTIVITIES: Proceeds from the exercises of
stock options 51 1,201 Repayment of debt -- (5,000) NET CASH
PROVIDED BY (USED IN) FINANCING ACTIVITIES 51 (3,799) Effect of
exchange rate change on cash -- (48) CHANGE IN CASH AND CASH
EQUIVALENTS 19,753 9,816 CASH AND CASH EQUIVALENTS, Beginning of
Period 15,045 42,225 CASH AND CASH EQUIVALENTS, End of Period
$34,798 $52,041 SUPPLEMENTAL DISCLOSURE OF NON-CASH OPERATING,
INVESTING, AND FINANCING ACTIVITIES: NON-CASH TRANSACTIONS Increase
in property and equipment included in accounts payable and accrued
liabilities $920 $-- Increase in transaction costs included in
other assets and accounts payable and accrued liabilities 1,401 --
Issuance of Restricted Stock $50 $-- DATASOURCE: Clarus Corporation
CONTACT: Nigel Ekern, Chief Administrative Officer of Clarus
Corporation, +1-203-428-2000, Web site: http://www.claruscorp.com/
Company News On-Call: http://www.prnewswire.com/comp/133360.html
Copyright
Clarus Therapeutics (MM) (NASDAQ:CLRS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Clarus Therapeutics (MM) (NASDAQ:CLRS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024